Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL

Clinical trial NCT07271121 · RECRUITING

Trial details

NCT number: NCT07271121
Sponsor: King Hussein Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Refractory/ Relapsed

Start date: 2025-02-12
Primary completion: 2028-03-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.